Live influenza vaccine. Beginning
Medical academic journal · 31.03.2026 · 26 (1) · 114-121
DOI: 10.17816/maj643541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical academic journal, online erschienen am 31.03.2026. Verfasst von Irina V. Kiseleva. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This review describes the very first stages of the development of a truly unique immunobiological preparation—the live attenuated intranasal influenza vaccine (LAIV). These initial stages determined the further directions of its development and laid the foundation for the modern live attenuated cold–adapted reassortant influenza vaccine. The Russian LAIV was developed by two outstanding Soviet and Russian virologists—Academician Anatoly Alexandrovich Smorodintsev and his student and colleague Galina Ibragimovna Alexandrova, professor, Dr. Sci. (Medicine). We would like to emphasize the priority of Russian scientists in the creation of this preparation, the American analogue of which appeared significantly later. To this day, our undisputed leadership is ignored by foreign researchers, and, as a rule, the abbreviation LAIV in foreign scientific reviews and articles is synonymous with the American vaccine only. Galina Ibragimovna Alexandrova dedicated her entire scientific life to the live attenuated influenza vaccine, starting with the isolation of the A/Leningrad/134/57 (H2N2) virus during the Asian flu pandemic and ending with the development of a whole series of passaged and reassortant cold–adapted vaccines for adults and children. Then came fame and international recognition, the triumphal march of the live attenuated influenza vaccine across the country, when hundreds and thousands of adults and children were vaccinated against influenza annually, dozens of patents and scientific articles, and the awarding of the honorary title of Honored Scientist of the Russian Federation... Galina Ibragimovna Alexandrova passed away on December 14, 2024, in her ninety-sixth year of life. This article is a tribute of deep respect to the memory of my Teacher.
Zitieren
APA
Kiseleva, I. V. (2026). Live influenza vaccine. Beginning. Medical academic journal, 26(1), 114-121. https://doi.org/10.17816/maj643541
Vancouver
Kiseleva IV. Live influenza vaccine. Beginning. Medical academic journal. 2026;26(1):114-121. doi:10.17816/maj643541
BibTeX
@article{Kiseleva2026,
author = {Kiseleva, Irina V.},
title = {Live influenza vaccine. Beginning},
journal = {Medical academic journal},
year = {2026},
volume = {26},
number = {1},
pages = {114--121},
doi = {10.17816/maj643541}
}
EUVIMED